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Commentary
Oscillations are everywhere in biology—the cell cycle, 
the heart beat, circadian rhythms, fertility cycles—life 
could not exist without them. They arise from time   
delays in the feedback circuits essential for regulating 
biological processes. As important as oscillations are to 
normal physiology, however, too many oscillators can 
spoil the broth of life. In the heart, the master oscillator 
is  the  sinus  node,  to  which  excitation–contraction   
coupling  and  the  metabolic  machinery  supporting   
cardiac  energetics  are  both  entrained.  In  this  issue, 
Ganitkevich  et  al.  describe  how  a  classical  biological   
oscillator, the glycolytic oscillator, can come into play 
during ischemia, and in doing so, compound its patho-
physiological consequences.
Previous studies have shown that glycolysis is capable 
of oscillating periodically, thought to be driven by the 
feedback loop in regulation of the key glycolytic enzyme 
phosphofructokinase  by  adenine  nucleotides  and   
other metabolites. Glycolytic oscillations have been 
most extensively characterized in yeast (Higgins, 1964; 
Hess and Boiteux, 1968), skeletal muscle extracts (Hess 
and Boiteux, 1971), and pancreatic  cells (Westermark 
and Lansner, 2003; Silva and Yunes, 2006). Glycolytic 
oscillations  in  isolated  cardiac  myocytes  were  first   
described by O’Rourke et al. (1994), who showed that 
myocytes deprived of glucose developed oscillations 
in action potential duration (APD) mediated by activa-
tion of sarcolemmal ATP-sensitive K (KATP) channels, 
metabolic sensors that shorten APD to reduce energy 
consumption when the ATP/ADP ratio falls. Recently, 
Yang et al. (2008) defined the conditions promoting 
glycolytic oscillations in cardiac myocytes more exten-
sively. Using chemical metabolic inhibitors, they found 
that when the capacity of oxidative phosphorylation 
and the creatine kinase (CK) system to stabilize the 
cellular ATP/ADP ratio becomes compromised, gly-
colysis is enabled to oscillate due to the feedback of 
adenine  nucleotides  on  phosphofructokinase  when 
the ATP/ADP ratio is no longer clamped by normally 
dominant aerobic metabolism.
However, in these prior studies (O’Rourke et al., 
1994; Ryu et al., 2005; Yang et al., 2008), metabolic   
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oscillations were induced under physiologically artifi-
cial conditions, involving complete glucose removal or 
chemical metabolic inhibition. Although some of the 
latter conditions are relevant to acute myocardial ische-
mia and anoxia, they are not identical to the real thing. 
The significance of the Ganitkevich et al. (2010) study 
is their demonstration that glycolytic oscillations occur 
under conditions directly relevant to clinical cardiac 
pathophysiology. Their elegant picochamber technique 
allows a single isolated patch-clamped myocyte to be   
imaged with fluorescent dyes during severe anoxia.   
Because the myocyte is bathed in only a very small   
volume of extracellular fluid, anoxic metabolites and 
ions such as lactate, protons, and K accumulate progres-
sively during anoxia. Thus, an isolated myocyte can be 
patch-clamped and imaged under conditions that re-
capitulate  fairly  accurately  the  features  of  genuine 
acute ischemia (anoxia with metabolite and ion accu-
mulation) in intact cardiac muscle.
Under normoxic conditions, mitochondria produce 
>95% of ATP used by the beating heart, with glycolysis 
and  glycogenolysis  generating  <5%.  High  levels  of   
creatine phosphate in heart cells facilitate ATP delivery 
evenly throughout the cytoplasm by regenerating ADP 
locally  via  CK.  Adenlyate  kinase,  which  converts  two 
ADPs to AMP and ATP, serves a complementary role in 
preserving a high ATP/ADP ratio throughout the cyto-
plasm. However, during acute ischemia or anoxia, mito-
chondrial control of the ATP/ADP ratio is suppressed 
by lack of oxygen, and CK is progressively inactivated   
by reactive oxygen species (ROS) and other factors   
(Mekhfi et al., 1996; Dolder et al., 2001). Anaerobic gly-
colysis becomes the majﾭor source of energy production, 
despite an inherently limited capacity to meet the full 
energy needs of the beating heart. The onset of irrevers-
ible injﾭury after 20–30 min of acute ischemia coincides 
with  the  progressive  inhibition  of  glycolysis  due  to   
lactate accumulation and acidosis (Ichihara et al., 1984; 
Weiss et al., 1996; Geraldes et al., 1997; Schaefer and 
Ramasamy, 1997; Rehring et al., 1998). During anoxia 
with maintained coronary perfusion, removal of exoge-
nous glucose as a substrate for glycolysis dramatically 
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oscillations are thought to be mediated by mitochondrial 
ROS–induced ROS release, involving either inner mem-
brane anion channels (Romashko et al., 1998) or mito-
chondrial permeability transitions pores (Brady et al., 
2004). Because of the requirement for ROS generation, 
mitochondrial  oscillations are more likely to occur 
during reperfusion than ischemia, when reoxygenation 
stimulates a burst of ROS production. However, the evi-
dence for mitochondrial  oscillations during genuine 
ischemia is still indirect (Akar et al., 2005).
In summary, when excitation–contraction–metabolism 
uncoupling  occurs,  rebellious  metabolic  oscillators 
become  potentially  important  factors  compounding 
ischemia reperfusion injﾭury in the heart. The study by 
Ganitkevich et al. (2010) documents that one form of 
these metabolic oscillations, arising from glycolysis, is 
directly  relevant  to  acute  anoxia  and  ischemia  in   
isolated  cardiac  myocytes.  The  next  frontier  is  to   
determine  whether  such  metabolic  oscillations  can 
be detected during acute ischemia in the intact heart, 
and if so, whether they play a role in hastening cell 
death.  Detection  of  metabolic  oscillations  in  intact   
tissue  is  technically  challenging.  Due  to  electrotonic 
coupling, APD in tissue represents the average of thou-
sands of cells, so that unless the phase of the underlying 
cellular  metabolic  oscillations  is  synchronized  in  a   
region  of  tissue, APD would not appear to oscillate.   
Attempts  to  directly  visualize  metabolic  oscillations   
during acute ischemia or anoxia in intact cardiac muscle   
using confocal imaging have so far been unrevealing 
(Matsumoto-Ida et al., 2006). Moreover, changes in 
  or  NADH  accompanying  glycolytic  oscillations 
are expected to be small. New genetically encoded fluo-
rescent ATP/ADP sensors (Berg et al., 2009; Imamura 
et  al.,  2009)  may  be  the  ideal  bioprobes  to  detect 
whether metabolic oscillations become at odds with 
the heart beat during acute ischemia/reperfusion in 
intact heart. If so, the relationship of such oscillations 
to cardioprotective signaling will become an interesting 
topic for study.
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accelerates cardiac injﾭury (Runnman et al., 1990). These 
observations  suggest  that  efficient  coupling  of  glyco-
lytic ATP production to cellular energy needs during 
acute ischemia and anoxia is crucial in protecting cells 
from  irreversible  injﾭury.  As  long  as  glycolytic  flux   
remains entrained to the heart beat, the myocyte has a 
chance to regulate energy balance appropriately. If   
glycolysis  begins  to  oscillate  independently,  however, 
the myocyte loses its ability to match cellular energy   
demands to energy needs, further exacerbating energy 
supply–demand imbalance and potentially accelerating 
the onset of irreversible injﾭury.
Ganitkevich et al. (2010) also show convincing evi-
dence that when glycolysis oscillates under these condi-
tions, the mitochondrial network secondarily oscillates 
in response. As glycolytic ATP production waxes, mito-
chondrial  F1-F0  ATP  synthase  reverses  and  consumes 
ATP to support mitochondrial membrane potential 
(). Conversely, as glycolytic ATP production wanes, 
mitochondria are less able to maintain  and par-
tially depolarize. The metabolic oscillations affect both 
cellular- and tissue-level functions. At the cellular level, 
consequences  to  excitation–contraction  coupling  are 
mediated through the activation of KATP channels, which 
shorten APD and depress the Ca transient when glyco-
lytically derived ATP levels are low phase, but lengthen 
APD and increase Ca transient amplitude when glyco-
lytic ATP production is in high phase (O’Rourke et al., 
1994). The latter phase inappropriately accelerates   
energy requirements and may exacerbate intracellular 
Ca overload, a known factor promoting injﾭury. At the 
tissue level, APD shortening during metabolic oscilla-
tions can lead to “metabolic sinks” that promote arrhyth-
mias (Akar et al., 2005).
As  multifunctional  signaling  proteins,  glycolytic   
enzymes  also  influence  cardioprotective  signaling   
(Juhaszova et al., 2004). Evidence linking glycolysis to 
cardioprotection  includes  the  finding  that  elevated   
extracellular glucose delays injﾭury by preserving glyco-
gen  stores  without  improving  overall  high  energy   
phosphate levels (Runnman et al., 1990), that the gly-
cogenolytic  enzyme  GSK-3  is  a  key  target  protein   
mediating cardioprotective signaling (Juhaszova et al., 
2004), and that enhanced glucose oxidation is cardio-
protective (Lopaschuk and Stanley, 2006).
These observations raise the intriguing possibility that 
by inducing excitation–contraction–metabolism uncou-
pling, glycolytic oscillations may promote injﾭury during 
ischemia and anoxia. In addition to glycolysis, the mito-
chondrial network can also escape its entrainment under 
conditions  of  increased  oxidative  stress  (Romashko   
et al., 1998; Brady et al., 2004). In this setting, mito-
chondria  become  prone  to  periodic,  cell-wide    
depolarization,  which  converts  mitochondria  into 
ATP consumers rather than producers, inducing KATP 
channel activation and APD shortening. The latter     Weiss and Yang 305
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